Achieve Life Sciences, Inc.ACHVNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

5 analysts·Limited coverage

100%

Rating Distribution

Strong Buy

00%

Buy

5100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 14% higher.

Bear Case

$4.00

-4%

Consensus

$4.75

+14%

Bull Case

$5.50

+32%

Price Range5 analysts

Low

Consensus

High

$4.00

$5.50

Current Target

Current Price

$4.18

Upside to Target

$0.57

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-1.25(5 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+676.81%

EPS—

FY2028

Rev+43.34%

EPS—

FY2029

Rev+77.31%

EPS+119.44%

Earnings Surprises

Beat rate:25%(3/12 quarters)

Avg surprise:-4.4%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

May 13, 2024Oppenheimer

Achieve Life Sciences (ACHV) PT Lowered to $11 at Oppenheimer

Target:$11.00

+354.5%from $2.42

Nov 16, 2022Maxim Group

Maxim Group Maintains Buy on Achieve Life Sciences, Lowers Price Target to $8

Target:$8.00

+608.0%from $1.13

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance